Despite its toxicity concerns, CA does not engage significant pathways associated with prostate cancer, such as the androgen receptor (AR) and estrogen receptor (ER), suggesting that it may not directly influence prostate cancer progression through these receptors. The gene discussed is ESR1; the disease is prostate cancer.